Cheng J B, Pillar J S, Conklyn M J, Breslow R, Shirley J T, Gerard N P, Showell H J
Department of Immunology and Infectious Diseases, Pfizer Inc., Groton, Connecticut 06340.
Pulm Pharmacol. 1990;3(4):171-9. doi: 10.1016/0952-0600(90)90013-9.
Naive guinea-pigs were passively sensitized with varying amounts of affinity column purified, homologous, anti-ovalbumin IgG1 (anti-OA IgG1) and then examined for a) the capacity of lung tissue to release mediators (histamine and LTB4/LTD4) in response to antigen-challenge ex vivo and b) the attendant circulating levels of anti-OA IgG1. Intraperitoneal administration of anti-OA IgG1 (0.125-0.75 mg/kg) to guinea-pigs facilitated the synthesis of LTB4 (8-25 ng/g lung) and LTD4 (18-80 ng/g) and the release of histamine (1-7 ug/g) from lung tissue after exposure to 10 micrograms/ml of ovalbumin for 20 min ex vivo. Peak levels of mediators were found using 0.5 mg/kg anti-OA IgG1 with an ED50 = 0.35 mg/kg. LTD4/LTB4 synthesis and histamine release were both antigen concentration- and time-dependent, and LT synthesis was observable in non-perfused lungs and in lungs perfused free of blood. Maximum sensitization occurred at 1-2 days post i.p. administration of anti-OA IgG1 and was maintained up to 7 days. Measurement of anti-OA IgG1 using an enzyme-linked immunosorbent assay demonstrated that circulating antibody levels were 2-6 micrograms/ml at the doses which caused sensitization. The level of anti-OA IgG1 found in passively sensitized animals was at least 100-fold less than that found in actively-sensitized guinea-pigs despite the similar magnitude in LTD4/LTB4 synthesized and the amount of histamine released. Using purified antibody, the results demonstrate that in guinea-pigs, IgG1 can play a prominent role in regulating lung LT synthesis and histamine release, and that microgram per ml circulating levels of this antibody are sufficient to sensitize naive lungs.
将不同量经亲和柱纯化的同源抗卵清蛋白IgG1(抗OA IgG1)被动致敏未接触过抗原的豚鼠,然后检测:a)肺组织在体外抗原激发后释放介质(组胺和白三烯B4/白三烯D4)的能力;b)随之出现的循环抗OA IgG1水平。给豚鼠腹腔注射抗OA IgG1(0.125 - 0.75 mg/kg)可促进白三烯B4(8 - 25 ng/g肺)和白三烯D4(18 - 80 ng/g)的合成以及在体外暴露于10微克/毫升卵清蛋白20分钟后肺组织中组胺(1 - 7微克/克)的释放。使用0.5 mg/kg抗OA IgG1时发现介质的峰值水平,半数有效剂量(ED50) = 0.35 mg/kg。白三烯D4/白三烯B4的合成和组胺释放均呈抗原浓度和时间依赖性,并且在未灌注肺和无血灌注肺中均可观察到白三烯的合成。腹腔注射抗OA IgG1后1 - 2天出现最大致敏作用,并维持至7天。使用酶联免疫吸附测定法对抗OA IgG1进行检测表明,在引起致敏的剂量下循环抗体水平为2 - 6微克/毫升。尽管被动致敏动物中合成的白三烯D4/白三烯B4量和释放的组胺量相似,但被动致敏动物中发现的抗OA IgG1水平比主动致敏豚鼠中发现的水平至少低100倍。使用纯化抗体的结果表明,在豚鼠中,IgG1在调节肺白三烯合成和组胺释放中可发挥重要作用,并且每毫升循环水平的微克级该抗体足以使未接触过抗原的肺致敏。